Welcome to Xi’an Good Doctor Medical Science and Technology Co., Ltd.website ！
Internet Drug Information Service Qualification Certificate: (Shaanxi)-Non-Operating -2023-0143
Clinical Trial Hospitals and Centers
Clinical Trial Sites
The GDHIPEC professional team is led by Professor Li, a pioneer in minimally invasive hyperthermic perfusion therapy. The team brings together a dynamic combination of senior, mid-career, and emerging professionals, including professor-level engineers, senior engineers, experienced clinical specialists, and experts in medical engineering, mechanical design, advanced manufacturing, marketing, and operations.
The team has established long-term collaborations with leading medical institutions in China, including Tangdu Hospital and Xijing Hospital of the Air Force Medical University, Nanjing Drum Tower Hospital, The First Hospital of Jilin University (Bethune First Hospital), Sichuan Provincial People’s Hospital, The First Hospital of Shanxi Medical University, The Second Hospital of Shanxi Medical University, and Anhui Provincial Hospital. These collaborations have strengthened the company’s capabilities in clinical research, technological innovation, and product development.
Driven by continuous innovation and close collaboration with clinical experts, GDHIPEC has built a robust intellectual property portfolio comprising 20 patents. Its Continuous Circulating Hyperthermic Perfusion Therapy System integrates multiple proprietary technologies to achieve precise, constant-temperature, multi-cavity perfusion while addressing key technical challenges associated with conventional intracavitary hyperthermic therapies, including HIPEC and HITHOC.
The company’s leadership and technical experts possess 25–30 years of experience in clinical medicine and medical engineering. Guided by a commitment to scientific innovation, clinical excellence, and patient-centered care, they are dedicated to delivering comprehensive, evidence-based clinical solutions for the prevention and treatment of tumor implantation and metastasis within body cavities, as well as the management of malignant effusions. Through continuous technological advancement and close collaboration with healthcare professionals, GDHIPEC strives to improve treatment outcomes, enhance patients’ quality of life, and advance the global development of hyperthermic perfusion therapy.
 |
 |
 |
 |
|
|
|
|
|
 |
 |
 |
 |
|
|
|
|
|
 |
 |
 |
 |
· GDHIPEC from China ,
· Caring for Patients Worldwide ·
Address: Floor 1-2, Left Building No. 1, Huoju Road, East zone of Xi’an High- tech Development District, Xi’an, China
Copyright Xi'an Good Doctor Medical Technology Co., Ltd.
Internet Drug Information Service Qualification Certificate (Shaanxi)-Non-Operating -2023-0143